Clinical Trials Directory

Trials / Sponsors / Corvus Pharmaceuticals, Inc.

Corvus Pharmaceuticals, Inc.

Industry · 10 registered clinical trials — 2 currently recruiting.

StatusTrialPhaseStarted
RecruitingStudy to Evaluate Soquelitinib in Participants With Moderate to Severe AD
Atopic Dermatitis, Atopic Dermatitis Eczema, Eczema
Phase 22026-02-01
RecruitingSoquelitinib vs Standard of Care in Participants With Relapsed/Refractory Peripheral T-cell Lymphoma Not Other
Peripheral T-Cell Lymphoma, Not Otherwise Specified, Angioimmunoblastic T-cell Lymphoma, Follicular T-Cell Lymphoma
Phase 32024-10-02
CompletedSafety, Tolerability, and Preliminary Efficacy of Soquelitinib in Participants With Moderate to Severe AD
Atopic Dermatitis
Phase 12024-04-16
TerminatedCPI-006 Plus Standard of Care Versus Placebo Plus Standard of Care in Mild to Moderately Symptomatic Hospitali
Covid-19
Phase 32021-02-25
CompletedStudy of CPI-006 as Immunotherapy for Hospitalized COVID-19 Patients
COVID-19
Phase 12020-07-01
CompletedStudy of Ciforadenant in Combination With Daratumumab in Patients With Relapsed or Refractory Multiple Myeloma
Multiple Myeloma
Phase 12020-02-20
Active Not RecruitingA Dose Escalation Study Evaluating CPI-818 in Relapsed/Refractory T-Cell Lymphoma
T-cell Lymphoma
Phase 12019-05-03
CompletedCPI-006 Alone and in Combination With Ciforadenant and With Pembrolizumab for Patients With Advanced Cancers
Non-Small Cell Lung Cancer, Renal Cell Cancer, Colorectal Cancer
Phase 12018-04-25
CompletedStudy to Evaluate the Pharmacokinetics of a New Tablet Formulation of CPI-444 in Fed and Fasted Healthy Male a
Healthy Subjects
Phase 12017-07-20
CompletedPhase 1/1b Study to Evaluate the Safety and Tolerability of Ciforadenant Alone and in Combination With Atezoli
Renal Cell Cancer, Metastatic Castration Resistant Prostate Cancer
Phase 12016-01-01